WO2003013585A8 - Mifaxin agonists and antagonists for use in the treatment of metabolic - Google Patents
Mifaxin agonists and antagonists for use in the treatment of metabolicInfo
- Publication number
- WO2003013585A8 WO2003013585A8 PCT/IB2002/003545 IB0203545W WO03013585A8 WO 2003013585 A8 WO2003013585 A8 WO 2003013585A8 IB 0203545 W IB0203545 W IB 0203545W WO 03013585 A8 WO03013585 A8 WO 03013585A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mifaxin
- agonists
- antagonists
- activity
- metabolic
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Physics & Mathematics (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31151001P | 2001-08-08 | 2001-08-08 | |
US60/311,510 | 2001-08-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003013585A1 WO2003013585A1 (en) | 2003-02-20 |
WO2003013585A8 true WO2003013585A8 (en) | 2003-04-17 |
Family
ID=23207219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2002/003545 WO2003013585A1 (en) | 2001-08-08 | 2002-08-06 | Mifaxin agonists and antagonists for use in the treatment of metabolic |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2003013585A1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69837678T2 (en) * | 1997-10-29 | 2007-12-27 | Otsuka Pharmaceutical Co., Ltd. | COMPOSITION FOR INHIBITING THE PROLIFERATION OF SMOOTH MUSCULATURE AND METHOD FOR THE DIAGNOSIS OF ARTERIOSCLEROSIS |
WO1999059618A1 (en) * | 1998-05-21 | 1999-11-25 | Smithkline Beecham Corporation | Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein) |
CA2365255A1 (en) * | 1999-03-24 | 2000-09-28 | Human Genome Sciences, Inc. | Human tumor necrosis factor receptor tr9 |
CA2372815A1 (en) * | 1999-05-11 | 2000-11-16 | Incyte Genomics, Inc. | Extracellular matrix and adhesion-associated proteins |
AU5159500A (en) * | 1999-05-27 | 2000-12-18 | Zymogenetics Inc. | Adipocyte complement related protein homolog zacrp7 |
ATE405655T1 (en) * | 2000-01-14 | 2008-09-15 | Serono Genetics Inst Sa | OBG3 GLOBULAR HEAD AND ITS USES FOR REDUCING BODY WEIGHT |
-
2002
- 2002-08-06 WO PCT/IB2002/003545 patent/WO2003013585A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003013585A1 (en) | 2003-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1600042I1 (en) | Therapeutic use of anti-CS1 antibodies | |
WO2005102387A3 (en) | Therapeutic use of anti-cs1 antibodies | |
WO2004047760A3 (en) | Novel chemical compounds | |
WO2004110376A3 (en) | Ccr-2 antagonists for treatment of neuropathic pain | |
WO2004056307A3 (en) | Disease treatment via antimicrobial peptide inhibitors | |
BR0315598A (en) | Neutralizing antibodies to gdf-8 and their uses | |
WO2003057698A3 (en) | Spiroazacyclic compounds as monoamine receptor modulators | |
EP1251126A3 (en) | Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation | |
AU2002258428A1 (en) | Methods for the treatment of metabolic disorders, including obesity and diabetes | |
AU2003299378A1 (en) | Method and compounds for inhibiting hec1 activity for the treatment of proliferative diseases | |
WO2001092330A3 (en) | Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation | |
WO2005070042A8 (en) | Novel chemical compounds | |
WO2003013578A8 (en) | Omoxin agonists and antagonists for use in the treatment of metabolic disorders | |
WO2003101953A3 (en) | Triazaspiro compounds useful for treating or preventing pain | |
WO2003013585A8 (en) | Mifaxin agonists and antagonists for use in the treatment of metabolic | |
WO2003013604A3 (en) | Migenix agonists and antagonists for use in the treatment of metabolic disorders | |
WO2003050281A3 (en) | Fragments of the human zn-alpha2-glycolprotein and their use in methods of treatment of obesity | |
AU2003255843A1 (en) | 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain | |
WO2007067516A3 (en) | Multiple myeloma | |
WO2003095485A3 (en) | Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders | |
WO2005094282A3 (en) | Combination therapy comprising cloretazinetm | |
WO2004053107A3 (en) | Methods for treating diabetes | |
WO2003030936A1 (en) | Remedies for life style-related diseases or cibophobia and method of screening the same | |
AU2002307819A1 (en) | Gssp4 polynucleotides and polypeptides and uses thereof | |
WO2004049917A3 (en) | Methods of therapy and diagnosis using targeting of cells that express ly-9 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
CFP | Corrected version of a pamphlet front page |
Free format text: UNDER (54) PUBLISHED TITLE REPLACED BY CORRECT TITLE |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase in: |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |